Navidea Biopharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-John K. Scott, Jr.(61.8%)
Navidea Biopharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-John K. Scott, Jr.(61.8%)
Navidea Biopharmaceuticals | 4:持股变动声明-董事 Scott John K Jr.
Navidea Biopharmaceuticals | 4:持股变动声明-董事 Moss Dana J
Navidea Biopharmaceuticals | 4:持股变动声明-董事 Stefanelli Jill
Navidea Biopharmaceuticals | 4:持股变动声明-首席财务官 Dais Craig
Navidea Biopharmaceuticals | 3:首次持股声明-首席财务官 Dais Craig
Navidea Biopharmaceuticals | 4:持股变动声明-董事 Moss Dana J
Navidea Biopharmaceuticals | 3:首次持股声明-董事 Moss Dana J
Navidea Biopharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-John K. Scott, Jr.(75.04%)
Navidea Biopharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Irwin Bain(4.73%)
Navidea Biopharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Irwin Bain(4.73%)
Navidea Biopharmaceuticals | 4:持股变动声明-董事 Scott John K Jr.
Navidea Biopharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-John K. Scott, Jr.(52.85%)
Navidea Biopharmaceuticals | 4:持股变动声明-董事 Scott John K Jr.
Navidea Biopharmaceuticals | 4:持股变动声明-董事 Stefanelli Jill
Navidea Biopharmaceuticals | 3:首次持股声明-董事 Stefanelli Jill
Navidea Biopharmaceuticals | 4/A:持股变动声明(修正)-董事 Witter Malcolm G
Navidea Biopharmaceuticals | 4:持股变动声明
Navidea Biopharmaceuticals | 4:持股变动声明
暂无数据
暂无数据